drug protocol number

NCT0571408

drug sponsor

Merck Sharp & Dohme KSA GmbH

drug study

Vericiguat

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase